Weiguo Qing
Corporate Officer/Principal at Hutchison MediPharma Ltd.
Profile
Weiguo Qing is currently the Vice President & Head-Oncology Research at Hutchison MediPharma Ltd.
He previously worked as a Principal at Abbott Laboratories and Roche Corp.
He holds a doctorate degree from The University of Texas at Austin and a graduate degree from the Institute of Materia Medica.
Weiguo Qing active positions
Companies | Position | Start |
---|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2007-12-31 |
Former positions of Weiguo Qing
Companies | Position | End |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Roche Corp. | Corporate Officer/Principal | - |
Training of Weiguo Qing
The University of Texas at Austin | Doctorate Degree |
Institute of Materia Medica | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private companies | 2 |
---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Roche Corp. |
- Stock Market
- Insiders
- Weiguo Qing